The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
Although the precise mechanisms contributing to secondary brain injury following traumatic brain injury are complex and obscure, a number of studies have demonstrated that inflammatory responses are an obvious and early feature in the pathogenesis of traumatic brain injury. Inflammasomes are multipr...
Main Authors: | Saifudeen Ismael, Heba A Ahmed, Tusita Adris, Kehkashan Parveen, Parth Thakor, Tauheed Ishrat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=1;spage=49;epage=57;aulast=Ismael |
Similar Items
-
Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury
by: Xin Xu, et al.
Published: (2018-09-01) -
Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
by: Yadong Zhai, et al.
Published: (2018-02-01) -
Pharmacological Inhibitors of the NLRP3 Inflammasome
by: Ayesha Zahid, et al.
Published: (2019-10-01) -
NLRP3 inflammasome and its inhibitors: a review
by: Bo-Zong eShao, et al.
Published: (2015-11-01) -
Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive
by: Mahmoud S. Sabra, et al.
Published: (2023-12-01)